Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?

Journal of Reproductive Immunology

Volumn 73, Issue 2, 2007, Pages 130-134

  Stepan, Holger ^a   Wallukat, Gerd ^b   Schultheiss, Heinz Peter ^c   Faber, Renaldo ^a   Walther, Thomas ^c,d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin II type 1 receptor; AT1 autoantibody; Parvovirus B19; Preeclampsia

Indexed keywords

ANGIOTENSIN 1 AUTOANTIBODY; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; AUTOANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; FEMALE; HUMAN; PARVOVIRUS; PERFUSION; PREECLAMPSIA; PREGNANCY; PRENATAL GROWTH; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SEROPREVALENCE; THIRD TRIMESTER PREGNANCY;

ANIMALS; ANTIBODIES, VIRAL; AUTOANTIBODIES; AUTOIMMUNITY; CAPSID PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MOLECULAR MIMICRY; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 33947178450     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2006.08.084     Document Type: Article

References (22)

1. Brown K.E., and Young N.S. Parvovirus B19 in human disease. Annu. Rev. Med. 48 (1997) 59-67
2. Cohen B.J., and Buckley M.M. The prevalence of antibody to human parvovirus B19 in England and Wales. J. Med. Microbiol. 25 (1988) 151-153
3. Davey D.A., and MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158 (1988) 892-898
4. Davison J.M., Homuth V., Jeyabalan A., et al. New aspects in the pathophysiology of preeclampsia. J. Am. Soc. Nephrol. 15 (2004) 2440-2448
5. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111 (2003) 649-658
6. Meekins J.W., Pijnenborg R., Hanssens M., et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 101 (1994) 669-674
7. Miyamura K., Kajigaya S., Momoeda M., et al. Parvovirus particles as platforms for protein presentation. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8507-8511
8. Oldstone M.B. Molecular mimicry and immune-mediated diseases. FASEB J. 12 (1988) 1255-1265
9. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
10. Stepan H., Heihoff-Klose A., and Faber R. Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion. Ultrasound Obstet. Gynecol. 23 (2004) 579-583
11. Stepan H., Geide A., and Faber R. Soluble fms-like tyrosine kinase 1. N. Engl. J. Med. 351 (2004) 2241-2242
12. Stepan H., and Faber R. Elevated sFlt1 level and preeclampsia in awoman with parvovirus-induced hydrops. N. Engl. J. Med. 354 (2006) 1857-1858
13. 2+ mobilization through angiotensin receptor activation. Circulation 110 (2004) 1612-1619
14. Tschöpe C., Bock C.T., Kasner M., Noutsias M., et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111 (2005) 879-886
15. Vallbracht K.B., Schwimmbeck P.L., Kuhl U., et al. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation 110 (2004) 2938-2945
16. Vecchi M.L., Radice A., Renda F., et al. Anti-laminin auto antibodies in ANCA-associated vasculitis. Nephrol. Dial. Transplant. 15 (2000) 1600-1603
17. Voigt M., and Schneider K.T.M. Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland. Teil 1: Neue Perzentilenkurven für die Körpergröße von Neugeborenen. Geburtsh. Frauenheilk. 56 (1996) 550-558
18. Wallukat G., Homuth V., Fischer T., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103 (1999) 945-952
19. Walther T., Wallukat G., Jank A., et al. The angiotensin II AT1 receptor autoimmune antibody reflects fundamental alterations of the utero-placental vasculature. Hypertension 46 (2005) 1275-1279
20. Xia Y., Wen H.Y., and Kellems R.E. Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation. J. Biol. Chem. 277 (2002) 24601-24608
21. Yeh S.P., Chiu C.F., Lee C.C., et al. Evidence of parvovirus B19 infection in patients of pre-eclampsia and eclampsia with dyserythropoietic anaemia. Br. J. Haematol. 126 (2004) 428-433
22. Zaki M., Greenwood C., Redman, et al. The spontaneous reversal of preeclampsia associated with parvovirus-induced hydrops and the placental theory of pre-eclampsia: a case report. Br. J. Obstet. Gynecol. 110 (2003) 1125-1126